Wolfe Peter 4
4 · ZyVersa Therapeutics, Inc. · Filed Jul 15, 2025
Insider Transaction Report
Form 4
Wolfe Peter
Chief Financial Officer
Transactions
- Award
Stock Options
2025-07-11+60,100→ 60,100 totalExercise: $0.59Exp: 2035-07-11→ Common Stock (60,100 underlying)
Footnotes (1)
- [F1]The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.